Rare diseases
Investigational molecules
Locations
Back to Spain1 112 clinical trials in Malaga, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity
SpainSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
SpainEffect of lenbelintide (AZD6234) on body weight in adults with type 2 diabetes and obesity or overweight
SpainEfficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
SpainPhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
SpainEffect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
SpainEfficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study
SpainA Phase 3 Randomized Study of Rozanolixizumab for Safety and Efficacy in Adults with Ocular Myasthenia Gravis
SpainPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
SpainRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
SpainContraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles
SpainPhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
SpainThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for cutaneous lupus erythematosus and myasthenia gravis, evaluating new therapeutic approaches to improve patient outcomes.
Studies aim to assess novel therapies' effectiveness in reducing disease activity and improving daily living activities.
Innovative vaccine development studies targeting COVID-19, cytomegalovirus, and respiratory syncytial virus, focusing on prevention and immune response.
Research emphasizes safety and immunogenicity in various population groups.
Advanced studies in bladder cancer, colorectal cancer, and gastric cancer, evaluating targeted therapies and combination treatments.
Trials focus on improving survival rates and treatment responses in various cancer types.
Research examining new treatments for chronic rhinosinusitis and COPD, with emphasis on symptom management and exacerbation prevention.
Studies evaluate novel therapeutic approaches for chronic respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
